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Volume 51, Number 11S Abstracts 63Sformed. Inter-rater and intra-rater reliability were com-
pared using Cohen’s Kappa and McNemar’s test,
respectively.
Results: Between 5/2008 and 8/2009, 7961 patients
were admitted to our trauma center, and 2153 (27%) under-
went a chest CTA. 25 (0.3%) patients (21 males, mean age
21.9 years) had a positive or equivocal study. Ten patients
underwent repair (9 endovascular, 1 open), and 15 patients
were managed medically. The 30-day mortality, paraplegia,
and stroke rate was zero. Equivocal results were more com-
monwith CTA images than with either IVUS or angiography
(27% vs 2.5 and 5%, respectively; overall p  0.0002). Com-
pared to Angio, IVUS changed the diagnosis in 13% of cases -
identifying injuries in 11% and ruling them out in 2%. Sensi-
tivity and specificity of angiography with respect to IVUS was
38% and 89%, respectively.
Conclusions: CTA is useful as a screening test in sus-
pected TAI. When additional imaging is required after an
equivocal CTA, IVUS is more sensitive than angiography.
Therefore, we advocate the use of IVUS in potential TAI
patients in whom angiography is being considered.
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Objectives: To compare outcomes of endovascular
(TEVAR) vs open repair of traumatic transaction of the
thoracic aorta (TTA).
Methods: The NIS, 2000-07, was used to identify
patients with an ICD9 diagnosis of TTA (901.0), and
procedure codes of either TEVAR (39.73), open (38.35,
38.45, and 39.57) or no repair.
Results:Of 9162 TTAs, 5667 received no intervention
(NI). Independent predictors of NI were age  60 (OR:
1.9; p 0.01), hospital in lowest income zip code (OR:1.4;
p  0.01), and abd/pel vessel injury (OR:1.6; p  0.05).
Female gender was the only independent predictor of open
repair vs TEVAR (OR:1.8 [1.1, 3.0]). Among treated
patients, TEVAR use increased from 2005-07 (14-67%).
Peripheral vascular disease (12 vs 5%, p 0.05) was higher
with TEVAR, as was mean age (42 vs 39 years; p  0.05).
Overall mortality was lower with any intervention than with
NI (14 vs 30%, p 0.01), and a trend existed towards lower
mortality with TEVAR over open (10 vs 15%, p  0.13).
Morbidity (general complications, amputation, dehiscence& prolonged ventilation), was lower with TEVAR (24 vs
34%, p  0.05) as was mean length of stay (LOS) (16 vs
21 d, p  0.01). Open repair was the only multivariate
predictor of postoperative morbidity (OR: 1.6 [1.0, 2.6]).
Conclusions: TEVAR is associated with lower overall
morbidity, shorter LOS, and a trend towards lower mortality,
while open repair is independently predictive of greater post-
operative morbidity. TEVAR for traumatic thoracic aortic
transections is preferred when anatomy and expertise allow.
Table: Comorbidities & Outcomes of TEVAR vs Open
Repair
VARIABLE TEVAR OPEN p value
Age (Mean  St. Dev.) 42.3  17.8 38.7  18.0 0.05
Male Gender 80.30% 69.30% 0.05
Peripheral Vascular Disease 12.10% 5.20% 0.05
Mortality 9.80% 15.40% 0.13
Morbidity Overall 23.60% 33.60% 0.05
LOS (Mean  St. Dev.) 15.6  14.4 20.8  18.8 0.01
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Objectives: Lower extremity venous stasis disease
could be related to outflow obstruction in the iliac-femoral
vein segments due to stenosis or extrinsic compression.
Conventional methods to assess these vein segments in-
clude trans-cutaneous ultrasonography and ascending
venography. The trans-cutaneous approach has a low sen-
sitivity, and venography can miss significant lesions as the
assessment is undertaken in a single view. We wanted to
assess the role of Intravenous ultrasound (IVUS) in detect-
ing the location as well as the degree of stenosis in the
iliac-femoral vein segments.
Methods: 104 patients with chronic lower extremity
venous stasis disease were evaluated for outflow obstruc-
tion/stenosis with ascending venography and IVUS. The
location and degree of any stenosis were noted. A signifi-
cant stenosis was defined as a 50% reduction in the diameter
of the vein relative to the adjacent vein segments. Patients
with significant stenosis underwent venous stenting to re-
store outflow. The results of venography and IVUS were
then compared.
Results: 46 (44.2%) patients had no evidence of stenosis
on either venography or IVUS and hence received no stents.
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lesions on IVUS. Among those, 10 (17.2%) patients had no
detectable lesion on venogram and would have been missed.
In 24 (41.4%), venography failed to identify all stenotic lesions
or resulted in in-accurate localization of the lesion. Only 24
(41.4%) patients had stenotic lesions on venogram that con-
formed anatomically to the lesions detected on IVUS.
Conclusions: In assessing patients with lower extrem-
ity venous stasis disease for iliac-femoral vein stenosis/
obstruction, venography alone can result in poor localiza-
tion (50% specificity) and can even miss significant stenotic
lesions (82.8% sensitivity). IVUS is a more sensitive and
accurate method, and should be included in all such evalu-
ations.
Author Disclosures: S. Alhalbouni: Nothing to disclose;
E. Ascher: Nothing to disclose; K. Gopal: Nothing to
disclose; A. Hingorani: Nothing to disclose; D. Jung:
Nothing to disclose; N. Marks: Nothing to disclose; A.
Shiferson: Nothing to disclose.
PS168.
Postoperative Morbidity and Mortality of Venous
Thrombectomy: A Review of the NSQIP Database
Eleftherios S. Xenos, Shane O’Keeffe, David Minion, Ehab
Sorial, Eric Endean. University of Kentucky and VA Med-
ical Center, Lexington, KY
Objectives: Surgical or pharmacomechanicalthrombus
removal has been shown to improve venous physiology in
acute iliofemoral deep venous thrombosis Our study fo-
cuses on the contemporary application of venous throm-
bectomy based on data from the National Surgical Quality
Improvement Program (ACS NSQIP).
Methods: Data submitted by over 200 hospitals to the
ACS NSQIP participant use file was accessed for the years
2005-2008. Patients were identified who had undergone
venous thrombectomy through leg access (Primary proce-
dure CPT 34421 or 34451). Demographic and clinical
variables along with thirty-day morbidity and mortality
were evaluated. Secondary/concomitant procedures CPT
codes were collected. Univariate analysis between groups
was performed using Chi2 or T-tests with p 0.05 consid-
ered significant.
Results: A total of 91 patients were identified who
underwent primary venous thrombectomy (67 CPT
34421, 24 CPT 34451). The mean age was 62.5  15.8 y
and 45 of 91 (49.5%) were female. Thirty-daymortality was
8.8% (8/91). Composite morbidity was 25.3% (23/91),
most frequently due to surgical site infection, and respira-
tory complications. Intraop transfusion (required in 18.7%
of the patients, was a significant predictor of postoperative
morbidity and mortality. Lower extremity fasciotomy was
performed in 8.8% of the patients and an inferior vena cava
(IVC) filter was placed in 2.2% of the patients, the incidence
of pulmonary embolism (PE) was 3.3%. An arteriovenousanastomosis was created in only one patient; venous angio-
plasty was performed in 3.3% of the patients.
Conclusions: Venous thrombectomy is associated
with significant postoperative morbidity and mortality and
should be propably limited to patients that are not candi-
cates for pharmacomechanical thrombolysis. Only two pa-
tients had an IVC filter placed during the operation but the
incidence of PE was low. Adjunctive procedures to assist
vein patency such as arteriovenous fistula creation or ve-
nous angioplasty were infrequently performed.
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Objectives: American Chest Physician (ACP) guide-
lines stratify DVT risk in trauma patients based on injury
pattern and use of medical prophylaxis. Screening is recom-
mended only for highest risk groups. Many screening stud-
ies for DVT did not investigated calf vein DVTs (CVDVT)
and did not exclusively target critically ill patients. Given
new ACP guidelines recommending treatment of calf vein
DVT, we investigated the efficacy of duplex ultrasound
screening (DUS) of critically ill trauma patients for all lower
extremity DVTs, including CVDVT, regardless of injury
pattern, risk factors, or medical prophylaxis.
Methods: The records of 264 intensive care unit
trauma patients who received DUS screening for lower
extremity DVT were examined for data on high-risk inju-
ries, DVT risk factors, and low molecular weight heparin
(LMWH) prophylaxis.
Results: 40 (15.2%) patients had DVTs found on DUS
screening, 25 (62.5%) were CVDVT, and 30% of all DVTs
were diagnosed within 1 week of admission. Patients without
high-risk injuries receiving LMWH had a 13.5% DVT rate,
which did not differ significantly from the 19.7% DVT rate in
high-risk injury patients not receiving LMWH (p  0.667).
Patientswithout high-risk injuries, and receivingLMWH,had
high rates of DVT even excluding other DVT risk factors.
Conclusions: Lower extremity DVT is common in crit-
ically ill trauma patients, particularly in the first week following
injury, regardless of injury pattern, DVT risk factors, or med-
ical prophylaxis. Previous studies have underestimated DVT
rates by not investigating CVDVTs. We recommend early
DVT screening of all critically ill trauma patients.
Author Disclosures: A. F. Azarbal: Nothing to disclose;
J. Lewis: Nothing to disclose; E. Mitchell: Nothing to
disclose; G. Moneta: Nothing to disclose; S. Moseley:
